Blister-pack integrity helps protect solid oral dosage forms from moisture, oxygen and contamination. The test method must reflect the package design and the actual failure modes; a passing visual inspection does not demonstrate that every seal is intact.

What failures are being detected?
Common risks include incomplete heat seals, channels, pinholes, formed-pocket damage, foil defects and handling damage. The critical defect size depends on product sensitivity, package materials, shelf life and intended storage. Define whether the objective is gross-leak screening, quantitative leak detection or evidence supporting barrier performance.
Dye ingress: strengths and limitations
Dye ingress typically exposes packages to a dye solution under defined pressure or vacuum conditions, then inspects for penetration. It can be useful for demonstrating visible leakage but is destructive, operator-dependent and affected by dye chemistry, wetting, pressure profile and defect geometry. Absence of visible dye is not proof of absolute package integrity.
Vacuum decay: how it works
Vacuum decay measures pressure changes in a test chamber under controlled vacuum. A leak may produce a detectable signal, but sensitivity depends on chamber volume, package compliance, headspace, temperature, stabilisation time and instrument capability. Flexible blister cavities can deform, so fixture design and method qualification are important.
Method development and validation
Use representative intact packs and deliberately defective samples, with a justified range of defect types and locations. Evaluate detection capability, false-positive and false-negative rates, repeatability, robustness, fixture setup and handling. Define what constitutes a valid test and a reportable failure.
Choosing a method
A destructive dye test may suit development or investigations, while a validated nondestructive method may support greater sampling or routine monitoring. Neither is inherently suitable for every blister format. Assess foil–foil versus foil–polymer construction, cavity geometry and product sensitivity before selecting the method.
Illustrative investigation
A packaging line begins showing sporadic failures near one edge of the blister web. Investigators compare seal temperature, pressure, dwell time, web tracking, forming quality and foil condition, then inspect affected machine lanes. The root cause should be demonstrated by corrective adjustment and successful challenge testing rather than assumed from a single pass.
GMP records and product impact
Retain approved test method, equipment qualification, package specifications, positive and negative controls, defect preparation records, batch and lane traceability, results, deviations and disposition. A confirmed integrity failure may require assessment of the affected manufacturing window and other packs, not just rejection of the tested sample.
Related articles and official guidance
Use this article for education and planning. Current pharmacopoeial requirements, approved methods, product specifications and site procedures govern GMP decisions.


